Chlamydia pneumoniae — an infectious risk factor for atherosclerosis?

Atherosclerosis--an inflammatory disease

Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725

Bergey's Manual of Systematic Bacteriology

(1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-5-391_3 · Cited by 15,601

Bergey's Manual of Systematic Bacteriology.

(1985) · Annals of Internal Medicine · doi:10.7326/0003-4819-102-1-151_3 · Cited by 4,886

Atherosclerosis

Lusis, A. J. (2000) · Nature · doi:10.1038/35025203 · Cited by 4,839

Mortality by cause for eight regions of the world: Global Burden of Disease Study

Murray, C. J., & Lopez, A. D. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07493-4 · Cited by 4,043

SEROLOGICAL EVIDENCE OF AN ASSOCIATION OF A NOVEL CHLAMYDIA, TWAR, WITH CHRONIC CORONARY HEART DISEASE AND ACUTE MYOCARDIAL INFARCTION

Saikku, P., Mattila, K., Nieminen, M. S., Huttunen, J. K., Leinonen, M., Ekman, M.-R., Mäkelä, P. H., & Valtonen, V (1988) · The Lancet · doi:10.1016/s0140-6736(88)90741-6 · Cited by 1,964

Endothelial Expression of a Mononuclear Leukocyte Adhesion Molecule During Atherogenesis

Cybulsky, M. I., & Gimbrone, M. A. (1991) · Science · doi:10.1126/science.1990440 · Cited by 1,712

ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree.

Nakashima, Y., Plump, A. S., Raines, E. W., Breslow, J. L., & Ross, R. (1994) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.14.1.133 · Cited by 1,693 · cited 1×

PECAM-1 is required for transendothelial migration of leukocytes.

Muller, W. A., Weigl, S. A., Deng, X., & Phillips, D. M. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.2.449 · Cited by 1,152

Interaction of chlamydiae and host cells in vitro

Moulder, J. W. (1991) · Microbiological Reviews · doi:10.1128/mmbr.55.1.143-190.1991 · Cited by 820

Chlamydia pneumoniae (TWAR)

Kuo, C. C., Jackson, L. A., Campbell, L. A., & Grayston, J. T. (1995) · Clinical Microbiology Reviews · doi:10.1128/cmr.8.4.451 · Cited by 819

Demonstration of Chlamydia pneumoniae in Atherosclerotic Lesions of Coronary Arteries

Kuo, C.-C., Shor, A., Campbell, L. A., Fukushi, H., Patton, D. L., & Grayston, J. T. (1993) · Journal of Infectious Diseases · doi:10.1093/infdis/167.4.841 · Cited by 762

Atherosclerosis in mice lacking apo E. Evaluation of lesional development and progression

Reddick, R. L., Zhang, S. H., & Maeda, N. (1994) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.14.1.141 · Cited by 633

Patterns of Vascular Cell Adhesion Molecule-1 and Intercellular Adhesion Molecule-1 Expression in Rabbit and Mouse Atherosclerotic Lesions and at Sites Predisposed to Lesion Formation

Iiyama, K., Hajra, L., Iiyama, M., Li, H., DiChiara, M., Medoff, B. D., & Cybulsky, M. I. (1999) · Circulation Research · doi:10.1161/01.res.85.2.199 · Cited by 632

Persistent chlamydiae: from cell culture to a paradigm for chlamydial pathogenesis

Beatty, W. L., Morrison, R., & Byrne, G. I. (1994) · Microbiological Reviews · doi:10.1128/mmbr.58.4.686-699.1994 · Cited by 588

Expression of intercellular adhesion molecule-1 in atherosclerotic plaques.

Poston, R. N., Haskard, D. O., Coucher, J., Gall, N. P., & Johnson-Tidey, R. R. (1992) · PubMed · Cited by 581

Chlamydial Heat Shock Protein 60 Localizes in Human Atheroma and Regulates Macrophage Tumor Necrosis Factor-α and Matrix Metalloproteinase Expression

Kol, A., Sukhova, G. K., Lichtman, A. H., & Libby, P. (1998) · Circulation · doi:10.1161/01.cir.98.4.300 · Cited by 538

Infection With Chlamydia pneumoniae Accelerates the Development of Atherosclerosis and Treatment With Azithromycin Prevents It in a Rabbit Model

Muhlestein, J. B., Anderson, J. L., Hammond, E. H., Zhao, L., Trehan, S., Schwobe, E. P., & Carlquist, J. F. (1998) · Circulation · doi:10.1161/01.cir.97.7.633 · Cited by 517

Chlamydial and human heat shock protein 60s activate human vascular endothelium, smooth muscle cells, and macrophages

Kol, A., Bourcier, T., Lichtman, A. H., & Libby, P. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5310 · Cited by 510

Virus-induced atherosclerosis.

Fabricant, C. G., Fabricant, J., Litrenta, M. M., & Minick, C. R. (1978) · The Journal of experimental medicine · doi:10.1084/jem.148.1.335 · Cited by 508

Isolation of Chlamydia pneumoniae from the Coronary Artery of a Patient with Coronary Atherosclerosis

Ramirez, J. A., & Chlamydia pneumoniae/Atherosclerosis Study Group* (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-12-199612150-00008 · Cited by 478

Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells

Gaydos, C. A., Summersgill, J. T., Sahney, N. N., Ramirez, J. A., & Quinn, T. C. (1996) · Infection and Immunity · doi:10.1128/iai.64.5.1614-1620.1996 · Cited by 442

Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques.

Shor, A., Kuo, C. C., & Patton, D. L. (1992) · PubMed · Cited by 407

Chlamydia pneumoniae sp. nov. for Chlamydia sp. Strain TWAR

GRAYSTON, J. T., KUO, C.-C., CAMPBELL, L. A., & WANG, S.-P. (1989) · International Journal of Systematic Bacteriology · doi:10.1099/00207713-39-1-88 · Cited by 379

Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15-34 years old).

Kuo, C. C., Grayston, J. T., Campbell, L. A., Goo, Y. A., Wissler, R. W., & Benditt, E. P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.15.6911 · Cited by 373

Endovascular Presence of Viable Chlamydia pneumoniaeIs a Common Phenomenon in Coronary Artery Disease 11This study was supported in part by the Research Commission of the Medical University of Lübeck (8/96) and the Deutsche Forschungsgemeinschaft (SFB 367/B2), Bonn, Germany.

Maass, M., Bartels, C., Engel, P. M., Mamat, U., & Sievers, H.-H. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00016-3 · Cited by 367

Detection of Chlamydia pneumoniae in aortic lesions of atherosclerosis by immunocytochemical stain.

Kuo, C. C., Gown, A. M., Benditt, E. P., & Grayston, J. T. (1993) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.13.10.1501 · Cited by 349

Azithromycin for the Secondary Prevention of Coronary Heart Disease Events: The WIZARD Study: A Randomized Controlled Trial

O'Connor, C. M., Dunne, M. W., Pfeffer, M. A., Muhlestein, J. B., Yao, L., Gupta, S., Benner, R. J., Fisher, M. R., Cook, T. D., & for the Investigators in the WIZARD Study (2003) · JAMA · doi:10.1001/jama.290.11.1459 · Cited by 328

Sarcoidosis and Other Granulomatous Disorders

James, D. G. (1988) · Postgraduate Medical Journal · doi:10.1136/pgmj.64.755.729 · Cited by 302

The atherogenic effects of chlamydia are dependent on serum cholesterol and specific to Chlamydia pneumoniae

Hu, H., Pierce, G. N., & Zhong, G. (1999) · Journal of Clinical Investigation · doi:10.1172/jci4582 · Cited by 297

High-level expression of Egr-1 and Egr-1–inducible genes in mouse and human atherosclerosis

McCaffrey, T. A., Fu, C., Du, B., Eksinar, S., Kent, K. C., Bush, H., Kreiger, K., Rosengart, T., Cybulsky, M. I., Silverman, E. S., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8592 · Cited by 294

Isolation of Chlamydia pneumoniae from a Carotid Endarterectomy Specimen

Jackson, L. A., Campbell, L. A., Kuo, C., Rodriguez, D. I., Lee, A., & Grayston, J. T. (1997) · The Journal of Infectious Diseases · doi:10.1086/517270 · Cited by 293

<EMPH TYPE="ITAL">Chlamydia pneumoniae</EMPH> as an Emerging Risk Factor in Cardiovascular Disease

Kalayoglu, M. V. (2002) · JAMA · doi:10.1001/jama.288.21.2724 · Cited by 283

Increase in the adhesion molecule P-selectin in endothelium overlying atherosclerotic plaques. Coexpression with intercellular adhesion molecule-1.

Johnson-Tidey, R. R., McGregor, J. L., Taylor, P., & Poston, R. N. (1994) · PubMed Central · Cited by 282

Background and Current Knowledge of Chlamydia pneumoniae and Atherosclerosis

Grayston, J. T. (2000) · The Journal of Infectious Diseases · doi:10.1086/315596 · Cited by 281

Evidence that Chlamydia pneumoniae Causes Pneumonia and Bronchitis

Grayston, J. T., Aldous, M. B., Easton, A., Wang, S.-P., Kuo, C.-C., Campbell, L. A., & Altman, J. (1993) · Journal of Infectious Diseases · doi:10.1093/infdis/168.5.1231 · Cited by 278

Induction of Macrophage Foam Cell Formation by Chlamydia pneumoniae

Kalayoglu, M. V., & Byrne, G. I. (1998) · The Journal of Infectious Diseases · doi:10.1086/514241 · Cited by 275

Evidence of Systemic Dissemination of Chlamydia pneumoniae via Macrophages in the Mouse

Moazed, T. C., Kuo, C., Grayston, J. T., & Campbell, L. A. (1998) · The Journal of Infectious Diseases · doi:10.1086/515280 · Cited by 264

Mechanism of C. trachomatis attachment to eukaryotic host cells

Zhang, J. P., & Stephens, R. S. (1992) · Cell · doi:10.1016/0092-8674(92)90296-o · Cited by 251

Murine Models of Chlamydia pneumoniae Infection and Atherosclerosis

Moazed, T. C., Kuo, C., Grayston, J. T., & Campbell, L. A. (1997) · The Journal of Infectious Diseases · doi:10.1086/513986 · Cited by 249

Chlamydia pneumoniae Infection in Circulating Human Monocytes Is Refractory to Antibiotic Treatment

Gieffers, J., Füllgraf, H., Jahn, J., Klinger, M., Dalhoff, K., Katus, H. A., Solbach, W., & Maass, M. (2001) · Circulation · doi:10.1161/01.cir.103.3.351 · Cited by 248

Pathways of Egr-1-Mediated Gene Transcription in Vascular Biology

Silverman, E. S., & Collins, T. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65312-6 · Cited by 248

Chlamydia pneumoniae Infection Accelerates the Progression of Atherosclerosis in Apolipoprotein E–Deficient Mice

Moazed, T. C., Campbell, L. A., Rosenfeld, M. E., Grayston, J. T., & Kuo, C. (1999) · The Journal of Infectious Diseases · doi:10.1086/314855 · Cited by 248

Chlamydia pneumoniae infection induces inflammatory changes in the aortas of rabbits

Laitinen, K., Laurila, A., Pyhälä, L., Leinonen, M., & Saikku, P. (1997) · Infection and Immunity · doi:10.1128/iai.65.11.4832-4835.1997 · Cited by 233

Chlamydia pneumoniae Infection of Vascular Smooth Muscle and Endothelial Cells Activates NF-κB and Induces Tissue Factor and PAI-1 Expression: A Potential Link to Accelerated Arteriosclerosis

Dechend, R., Maass, M., Gieffers, J., Dietz, R., Scheidereit, C., Leutz, A., & Gulba, D. C. (1999) · Circulation · doi:10.1161/01.cir.100.13.1369 · Cited by 227

High Prevalence of Chlamydia pneumoniae DNA in Peripheral Blood Mononuclear Cells in Patients with Cardiovascular Disease and in Middle‐Aged Blood Donors

Boman, J., Söderberg, S., Forsberg, J., Birgander, L. S., Allard, A., Persson, K., Jidell, E., Kumlin, U., Juto, P., Waldenström, A., et al. (1998) · The Journal of Infectious Diseases · doi:10.1086/517452 · Cited by 226

Global Stage-Specific Gene Regulation during the Developmental Cycle of Chlamydia trachomatis

Nicholson, T. L., Olinger, L., Chong, K., Schoolnik, G., & Stephens, R. S. (2003) · Journal of Bacteriology · doi:10.1128/jb.185.10.3179-3189.2003 · Cited by 221

Specificity of detection of Chlamydia pneumoniae in cardiovascular atheroma: evaluation of the innocent bystander hypothesis.

Jackson, L. A., Campbell, L. A., Schmidt, R. A., Kuo, C. C., Cappuccio, A., Lee, M. J., & Grayston, J. T. (1997) · Europe PMC (PubMed Central) · Cited by 206

Chlamydia trachomatis-host cell interactions: role of the chlamydial major outer membrane protein as an adhesin

Su, H., Watkins, N. G., Zhang, Y. X., & Caldwell, H. D. (1990) · Infection and Immunity · doi:10.1128/iai.58.4.1017-1025.1990 · Cited by 200

In vitro susceptibility of human vascular wall cells to infection with Chlamydia pneumoniae

Godzik, K. L., O'Brien, E. R., Wang, S. K., & Kuo, C. C. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.9.2411-2414.1995 · Cited by 189

Chlamydial Infections

Schachter, J., & Alexander, E. R. (2009) · Bacterial Infections of Humans · doi:10.1007/978-0-387-09843-2_11 · Cited by 173

Identification of a new group of Chlamydia psittaci strains called TWAR

Kuo, C. C., Chen, H. H., Wang, S. P., & Grayston, J. T. (1986) · Journal of Clinical Microbiology · doi:10.1128/jcm.24.6.1034-1037.1986 · Cited by 172

Entry of genital Chlamydia trachomatis into polarized human epithelial cells

Wyrick, P. B., Choong, J., Davis, C. H., Knight, S. T., Royal, M. O., Maslow, A. S., & Bagnell, C. R. (1989) · Infection and Immunity · doi:10.1128/iai.57.8.2378-2389.1989 · Cited by 155

Hydroxymethylglutaryl Coenzyme A Reductase Inhibitors Modify the Inflammatory Response of Human Macrophages and Endothelial Cells Infected With Chlamydia pneumoniae

Kothe, H., Dalhoff, K., Rupp, J., Müller, A., Kreuzer, J., Maass, M., & Katus, H. A. (2000) · Circulation · doi:10.1161/01.cir.101.15.1760 · Cited by 151

Chlamydial Infections

Batteiger, B. E., & Jones, R. B. (1987) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(20)30097-0 · Cited by 147

Structure and function of adhesion receptors in leukocyte trafficking

Hogg, N., & Berlin, C. (1995) · Immunology Today · doi:10.1016/0167-5699(95)80147-2 · Cited by 144

Potential Infectious Etiologies of Atherosclerosis: A Multifactorial Perspective

O’Connor, S., Taylor, C. E., Campbell, L. A., Epstein, S. E., & Libby, P. (2001) · Emerging infectious diseases · doi:10.3201/eid0705.010503 · Cited by 133

Herpesvirus-induced atherosclerosis in chickens.

Fabricant, C. G., Fabricant, J., Minick, C. R., & Litrenta, M. M. (1983) · PubMed · Cited by 133

Growth of Chlamydia pneumoniae induces cytokine production and expression of CD14 in a human monocytic cell line

Heinemann, M., Šuša, M., Simnacher, U., Marre, R., & Essig, A. (1996) · Infection and Immunity · doi:10.1128/iai.64.11.4872-4875.1996 · Cited by 130

Expression of adhesion molecules on endothelial cells stimulated byChlamydia pneumoniae

Kaukoranta-Tolvanen, S.-S. E., Ronni, T., Leinonen, M., et al. (1996) · Microbial Pathogenesis · doi:10.1006/mpat.1996.0071 · Cited by 125

Serological response to Chlamydia pneumoniae in adults with coronary arterial fatty streaks and fibrolipid plaques

Puolakkainen, M. H., Kuo, C. C., Shor, A., Wang, S.-P., Grayston, J. T., & Campbell, L. A. (1993) · Journal of Clinical Microbiology · doi:10.1128/jcm.31.8.2212-2214.1993 · Cited by 118

Chlamydia pneumoniae Infection Does Not Induce or Modify Atherosclerosis in Mice

Caligiuri, G., Rottenberg, M. E., Nicoletti, A., Wigzell, H., & Hansson, G. K. (2001) · Circulation · doi:10.1161/01.cir.103.23.2834 · Cited by 114

De Novo Induction of Atherosclerosis by Chlamydia pneumoniae in a Rabbit Model

Fong, I. W., Chiu, B., Viira, E., Jang, D., & Mahony, J. B. (1999) · Infection and Immunity · doi:10.1128/iai.67.11.6048-6055.1999 · Cited by 113

Chlamydia pneumoniae and atherosclerosis – what we know and what we don't

Ngeh, J., Anand, V., & Gupta, S. (2002) · Clinical Microbiology and Infection · doi:10.1046/j.1469-0691.2002.00382.x · Cited by 107

Atherosclerosis in apoE Knockout Mice Infected with Multiple Pathogens

Burnett, M. S., Gaydos, C. A., Madico, G. E., Glad, S. M., Paigen, B. J., Quinn, T. C., & Epstein, S. E. (2001) · The Journal of Infectious Diseases · doi:10.1086/317938 · Cited by 103

Endothelial Dysfunction After RepeatedChlamydia pneumoniaeInfection in Apolipoprotein E–Knockout Mice

Liuba, P., Karnani, P., Pesonen, E. J., Paakkari, I., Forslid, A., Johansson, L., Persson, K., Wadström, T., & Laurini, R. (2000) · Circulation · doi:10.1161/01.cir.102.9.1039 · Cited by 99

Chlamydial Virulence Determinants in Atherogenesis: The Role of Chlamydial Lipopolysaccharide and Heat Shock Protein 60 in Macrophage‐Lipoprotein Interactions

Kalayoglu, M. V., Morrison, R. P., Morrison, S. G., Yuan, Y., & Byrne, G. I. (2000) · The Journal of Infectious Diseases · doi:10.1086/315619 · Cited by 91

Detection ofChlamydia pneumoniaein Arterial Tissues

Kuo, C., & Campbell, L. A. (2000) · The Journal of Infectious Diseases · doi:10.1086/315615 · Cited by 88

Association of circulating Chlamydia pneumoniaeDNA with cardiovascular disease: a systematic review

Smieja, M., Mahony, J. B., Petrich, A. K., Boman, J., & Chernesky, M. (2002) · BMC Infectious Diseases · doi:10.1186/1471-2334-2-21 · Cited by 86

Effect of Azithromycin on Murine Arteriosclerosis Exacerbated byChlamydia pneumoniae

Rothstein, N. M., Quinn, T. C., Madico, G. E., Gaydos, C. A., & Lowenstein, C. J. (2001) · The Journal of Infectious Diseases · doi:10.1086/317941 · Cited by 76

Antibiotic Treatment of Atherosclerotic Cardiovascular Disease

Grayston, J. T. (2003) · Circulation · doi:10.1161/01.cir.0000056032.56396.89 · Cited by 72

Chlamydia pneumoniae Induces Inflammatory Changes in the Heart and Aorta of Normocholesterolemic C57BL/6J Mice

Blessing, E., Lin, T., Campbell, L. A., Rosenfeld, M. E., Lloyd, D. M., & Kuo, C. (2000) · Infection and Immunity · doi:10.1128/iai.68.8.4765-4768.2000 · Cited by 70

Chlamydia pneumoniaein Atherosclerotic Tissue

Taylor-Robinson, D. C., & Thomas, B. J. (2000) · The Journal of Infectious Diseases · doi:10.1086/315614 · Cited by 66

Chlamydia pneumoniae Does Not Increase Atherosclerosis in the Aortic Root of Apolipoprotein E–Deficient Mice

Aalto‐Setälä, K., Laitinen, K., Erkkilä, L., Leinonen, M., Jauhiainen, M., Ehnholm, C., Tamminen, M., Puolakkainen, M. H., Penttilä, I., & Saikku, P. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.21.4.578 · Cited by 65

Hydroxymethylglutaryl Coenzyme A Reductase Inhibition Reduces Chlamydia pneumoniae -Induced Cell Interaction and Activation

Dechend, R., Gieffers, J., Dietz, R., Joerres, A., Rupp, J., Luft, F. C., & Maass, M. (2003) · Circulation · doi:10.1161/01.cir.0000083367.93022.78 · Cited by 61

Interactions ofChlamydia pneumoniaewith Human Endothelial Cells

Summersgill, J. T., Molestina, R. E., Miller, R. D., et al. (2000) · The Journal of Infectious Diseases · doi:10.1086/315620 · Cited by 57

Effects of two antibiotic regimens on course and persistence of experimental Chlamydia pneumoniae TWAR pneumonitis

Malinverni, R., Kuo, C. C., Campbell, L. A., Lee, A., & Grayston, J. T. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.1.45 · Cited by 53

Chlamydia pneumoniae infection induces an unstable atherosclerotic plaque phenotype in LDL-receptor, ApoE double knockout mice

Ezzahiri, R., Stassen, F. R. M., Kurvers, H. A. J. M., van Pul, M. M. L., Kitslaar, P. J. E. H. M., & Bruggeman, C. A. (2003) · European Journal of Vascular and Endovascular Surgery · doi:10.1053/ejvs.2002.1913 · Cited by 52

Mannose-receptor positive and negative mouse macrophages differ in their susceptibility to infection byChlamydia species

Kuo, C., Puolakkainen, M. H., Lin, T., Witte, M., & Campbell, L. A. (2002) · Microbial Pathogenesis · doi:10.1006/mpat.2001.0479 · Cited by 43

-infected monocytes exhibit increased adherence to human aortic endothelial cells

Kalayoglu, M. V., Perkins, B. N., & Byrne, G. I. (2001) · Microbes and Infection · doi:10.1016/s1286-4579(01)01458-7 · Cited by 42

Monocyte–Endothelial Cell Coculture Enhances Infection of Endothelial Cells withChlamydia pneumoniae

Lin, T., Campbell, L. A., Rosenfeld, M. E., & Kuo, C. (2000) · The Journal of Infectious Diseases · doi:10.1086/315349 · Cited by 36

Chlamydia pneumoniaeInfection of Endothelial Cells Induces Transcriptional Activation of Platelet‐Derived Growth Factor–B: A Potential Link to Intimal Thickening in a Rabbit Model of Atherosclerosis

Coombes, B. K., Chiu, B., Fong, I. W., & Mahony, J. B. (2002) · The Journal of Infectious Diseases · doi:10.1086/340415 · Cited by 36

Chlamydia pneumoniaein Atherosclerotic and Nonatherosclerotic Tissue

Ouchi, K., Fujii, B., Kudo, S., Shirai, M., Yamashita, K., Gondo, T., Ishihara, T., Ito, H., & Nakazawa, T. (2000) · The Journal of Infectious Diseases · doi:10.1086/315617 · Cited by 27

Effect of short-term antibiotic treatment on chlamydia pneumoniae and peripheral endothelial function

Kuvin, J. T., Gokce, N., HOLBROOK, M. M., Hunter, L. M., Patel, A. R., Sliney, K. A., Craven, D. E., Grayston, J. T., Keaney, J. F., Karas, R. H., et al. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)03417-3 · Cited by 10

Human oral, gut, and plaque microbiota in patients with atherosclerosis

Koren, O., Spor, A., Felin, J., Fåk, F., Stombaugh, J., Tremaroli, V., Behre, C. J., Knight, R., Fagerberg, B., Ley, R. E., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011383107 · Cited by 1,196

An early-stage atherosclerosis research model based on microfluidics

Zheng, W., Huang, R., Jiang, B., Zhao, Y., Zhang, W., & Jiang, X. (2016) · Small · doi:10.1002/smll.201503241 · Cited by 97

Chlamydia pneumoniae: An Etiologic Agent for Late-Onset Dementia

Balin, B. J., Hammond, C. J., Little, C. S., Hingley, S. T., Al-Atrache, Z., Appelt, D. M., Whittum-Hudson, J. A., & Hudson, A. P. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00302 · Cited by 77

Neutrophil gelatinase-associated lipocalin and interleukin-10 regulate intramacrophage Chlamydia pneumoniae replication by modulating intracellular iron homeostasis

Bellmann-Weiler, R., Schroll, A., Engl, S., Nairz, M., Talasz, H., Seifert, M., & Weiss, G. (2013) · Immunobiology · doi:10.1016/j.imbio.2012.11.004 · Cited by 43

Trace element balance is changed in infected organs during acute Chlamydophila pneumoniae infection in mice

Edvinsson, M., Frisk, P., Molin, Y., Hjelm, E., & Ilbäck, N.-G. (2008) · BioMetals · doi:10.1007/s10534-007-9114-7 · Cited by 22